Skip to main content
Toggle navigation
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yahya, Nawal
Mayo Clinic
LB-015
-
POPULATION PHARMACOKINETICS OF THE PARP INHIBITOR VELIPARIB IN PATIENTS WITH ADVANCED CANCER.
Nawal Yahya
Favorite
Yang, Derek
Pfizer Inc.
PII-082
-
POPULATION EXPOSURE-RESPONSE ANALYSIS OF INOTUZUMAB OZOGAMICIN EFFICACY AND SAFETY IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Derek Yang
Favorite
PII-083
-
POPULATION PHARMACOKINETIC (POPPK) MODELING OF ENCORAFENIB (ENCO) IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH BRAF V600-MUTANT SOLID TUMORS IN PHASE 1, 2, AND 3 STUDIES: A SEMIMECHANISTIC AUTOINDUCTION MODEL.
Derek Yang
Favorite
Yang, Eunsol
University of California, San Francisco
PI-020
-
PREDICTING OPTIMAL PATIENT-CENTRIC TREATMENT DURATION FOR LEVOFLOXACIN-CONTAINING TUBERCULOSIS REGIMEN: AN INTEGRATED APPROACH OF A MODEL-BASED STRATIFICATION TOOL WITH SITE-OF-DISEASE PHARMACOLOGY KNOWLEDGE
Eunsol Yang
Favorite
PII-019
-
POPULATION PHARMACOKINETICS OF DELAMANID AND ITS METABOLITE DM-6705 IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS RECEIVING NOVEL SHORT-COURSE ORAL REGIMENS IN THE ENDTB AND ENDTB-Q TRIALS
Eunsol Yang
Favorite
Yang, HyeokJun
jeju National University
PII-126
-
DEVELOPMENT OF A SKIN DRYNESS PREDICTION MODEL BASED ON FACIAL IMAGES USING DEEP LEARNING: A PROSPECTIVE COHORT STUDY.
HyeokJun Yang
Favorite
Yang, Jia
UCSF
PI-041
-
A COMPREHENSIVE DEEP MUTATIIONAL SCAN OF OATP1B1: IMPLICATIONS FOR DRUG RESPONSE
Jia Yang
Favorite
Yang, Xinning
US Food and Drug Administration
LB-022
-
CAN THE POTENTIAL OF A DRUG TO INHIBIT URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE (UGT) ENZYMES BE PREDICTED? INSIGHTS FROM A RETROSPECTIVE ANALYSIS.
Xinning Yang
Favorite
Yoon, Michael
University of California, San Francisco
PT-025
-
EVALUATION OF PYRAZINAMIDE PHARMACOKINETICS IN ADOLESCENTS AND ADULTS TO INFORM TUBERCULOSIS DOSING RECOMMENDATIONS.
Michael Yoon
Favorite
Yoshihara, Tatsuya
SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center
PI-050
-
INFLUENCE OF ALDH2 RS671 POLYMORPHISM ON ANTIBODY TITER AFTER INFLUENZA VACCINATION: A PROSPECTIVE OBSERVATIONAL STUDY
Tatsuya Yoshihara
Favorite
Yu, Amanda
UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
PI-057
-
AN INVESTIGATION INTO THE DOSE-DEPENDENT FOOD-EFFECT FOR DRUGS.
Amanda Yu
Favorite
Yu, Sijia
Department of Pharmaceutics and Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey
PT-028
-
MITIGATING CARDIOTOXICITY OF TRASTUZUMAB AND DOXORUBICIN COMBINATION THERAPY WITH AN INTEGRATED TRANSLATIONAL AND QUANTITATIVE SYSTEMS TOXICOLOGY AND PBPK/PD MODELING APPROACH
Sijia Yu
Favorite
PWII-004
-
MITIGATING CARDIOTOXICITY OF TRASTUZUMAB AND DOXORUBICIN COMBINATION THERAPY WITH AN INTEGRATED TRANSLATIONAL AND QUANTITATIVE SYSTEMS TOXICOLOGY AND PBPK/PD MODELING APPROACH
Sijia Yu
Favorite
YU, XIAOYI
MSD R&D (China) Co., Ltd.
PI-070
-
IMPACT OF EAST ASIAN ETHNICITY ON PHARMACOKINETICS OF SOTATERCEPT
XIAOYI YU
Favorite